Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
- PMID: 11171827
- PMCID: PMC1760130
- DOI: 10.1136/gut.48.3.367
Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
Abstract
Background: Ulcerative colitis associated colorectal cancer (UCACRC) has several distinctive clinicopathological and genetic features which differ from sporadic colorectal cancer (SCRC). Hypermethylation of the E-cadherin gene (CDH1) has not been described previously in colorectal cancer.
Aims: A panel of SCRC and UCACRC were investigated for mutations in CDH1, and for hypermethylation of the promoter region of CDH1.
Subjects and methods: DNA was available from 14 patients with UCACRC and from 14 with SCRC. All exons of CDH1 were amplified with the polymerase chain reaction (PCR) and screened using single strand conformational polymorphism and direct sequencing. Hypermethylation of the CDH1 promoter region was determined by methylation specific PCR following bisulphite modification, and compared with E-cadherin protein expression from a previous immunohistochemistry study.
Results: Thirteen of 28 cancers (46%) were hypermethylated in the CDH1 promoter region-eight cancers (57%) in the UCACRC group and five cancers (36%) in the SCRC group (NS)-and this correlated with reduced E-cadherin expression (p<0.05). There was a trend for methylation to be associated with a more advanced stage of cancer although this did not reach statistical significance. There were no mutations in CDH1 in either group although there were several polymorphisms.
Conclusion: We have demonstrated hypermethylation of the promoter region in CDH1 in 46% of colorectal cancers studied. There was no difference between the UCACRC and SCRC groups. Just as there are specific differences in the genetic changes between UCACRC and SCRC, there is also likely to be a large degree of overlap among the genetic pathways of these cancers.
Figures
Similar articles
-
Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.Genes Chromosomes Cancer. 2002 Oct;35(2):121-6. doi: 10.1002/gcc.10101. Genes Chromosomes Cancer. 2002. PMID: 12203775
-
Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.Gut. 1997 May;40(5):654-9. doi: 10.1136/gut.40.5.654. Gut. 1997. PMID: 9203946 Free PMC article.
-
CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.BMC Cancer. 2006 Mar 2;6:48. doi: 10.1186/1471-2407-6-48. BMC Cancer. 2006. PMID: 16512896 Free PMC article.
-
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.Ann Oncol. 2004 Mar;15(3):489-92. doi: 10.1093/annonc/mdh108. Ann Oncol. 2004. PMID: 14998854
-
CDH1 (E-cadherin) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story.Cancers (Basel). 2022 Sep 8;14(18):4377. doi: 10.3390/cancers14184377. Cancers (Basel). 2022. PMID: 36139537 Free PMC article. Review.
Cited by
-
Folic acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile.J Exp Clin Cancer Res. 2011;30(1):116. doi: 10.1186/1756-9966-30-116. Epub 2011 Dec 29. J Exp Clin Cancer Res. 2011. PMID: 22206623 Free PMC article.
-
Emerging mechanisms progress of colorectal cancer liver metastasis.Front Endocrinol (Lausanne). 2022 Dec 8;13:1081585. doi: 10.3389/fendo.2022.1081585. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36568117 Free PMC article. Review.
-
Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate _target genes.Hum Mol Genet. 2011 Jul 15;20(14):2879-88. doi: 10.1093/hmg/ddr190. Epub 2011 Apr 29. Hum Mol Genet. 2011. PMID: 21531788 Free PMC article.
-
DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.Dig Dis Sci. 2014 Oct;59(10):2444-51. doi: 10.1007/s10620-014-3193-4. Epub 2014 May 10. Dig Dis Sci. 2014. PMID: 24825593
-
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.Aliment Pharmacol Ther. 2013 Mar;37(5):546-54. doi: 10.1111/apt.12218. Epub 2013 Jan 24. Aliment Pharmacol Ther. 2013. PMID: 23347191 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous